Cargando…
Review of current and future therapeutics in ABPA
Allergic bronchopulmonary aspergillosis is an allergic pulmonary condition caused by hypersensitivity to antigens of Aspergillus sp. found most commonly in patients with underlying asthma or cystic fibrosis. Host factors which alter the innate and adaptive immune responses to this abundant airborne...
Autores principales: | Lewington-Gower, Elisa, Chan, Ley, Shah, Anand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543630/ https://www.ncbi.nlm.nih.gov/pubmed/34729149 http://dx.doi.org/10.1177/20406223211047003 |
Ejemplares similares
-
Bronchial asthma with ABPA presenting as PTE
por: Azad, Chandrika, et al.
Publicado: (2013) -
Basophil Activation Test With Aspergillus Molecules: The Case for ABPA
por: Michel, Moïse, et al.
Publicado: (2022) -
Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?
por: Agarwal, Ritesh, et al.
Publicado: (2021) -
Aspergillus march: from ABPA to aspergilloma to subacute invasive aspergillosis
por: Dogra, Vikas, et al.
Publicado: (2016) -
Pulmonary actinomycosis and polymicrobial empyema in a patient with ABPA and bronchocoele
por: Tu, Jacky, et al.
Publicado: (2022)